A Study to Evaluate Resilience After Stroke for Survivors and Caregivers

Overview

About this study

The purpose of this study is to test the feasibility of providing a mindfulness based stress management intervention, the Resilient Living Program,to stroke survivors and their family caregivers. The Resilient Living Program consists of an introduction and 4 online modules, each completed  2 weeks apart. Stroke survivors and their caregivers will practice the strategies taught in the modules using a journal to record. Questionnaires to gauge the impact of the intervention will be completed at baseline, 5, 9, and 12 weeks.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria - Stroke Survivors:

  • Age ≥ 18 years old.
  • Admitted to Mayo Clinic Rehabilitation Unit with diagnosis of stroke or brain tumor.
  • English fluency.
  • No diagnosed severe cognitive impairment (determined through clinician report and/or medical record documentation).
  • Provide written (paper or electronic) informed consent.
  • Ability to complete questionnaire(s) by themselves or with assistance.
  • Have ability to utilize the technology to watch online modules.

Inclusion Criteria - Caregivers:

  • Age ≥ 18 years old.
  • English fluency.
  • Identifies as a caregiver for a stroke survivor or person with BT and lives with the care recipient at least 50% of the time.
  • No diagnosed severe cognitive impairment (determined through self report).
  • Have ability to utilize the technology to watch online modules.

Exclusion Criteria:

  • Individuals < 18 years old.
  • As determined through self-report, those diagnosed with a history of a psychotic episode.
  • Documented psychological comorbidities such as untreated schizophrenia, bipolar disease.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Sherry Chesak, Ph.D., M.S., R.N.

Closed for enrollment

Contact information:

Sara Herrick

(507) 284-2197

Herrick.Sara@mayo.edu

More information

Publications

Publications are currently not available